Michael Dickinson/LinkedIn
Jun 20, 2025, 15:33
Michael Dickinson: COALITION Study is online JCO ASCO – An IIT and the 1st Bispecific Glofitamab in High-Risk DLBCL
Michael Dickinson, Haematologist, Professor at the University of Melbourne, shared a post on X:
“COALITION is online JCO ASCO – an IIT and the FIRST bispecific glofitamab First Line trial to target very high risk DLBCL lymphoma in younger patients. Great work from Adrian Minson and thanks to investigators and teams across Oz. 18ICML and thanks to Peter Mac Cancer Centre.
Some interesting observations about pet scans in the context of front line bispecific and also some mrd data that will interest many.“
Title: Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Authors: Adrian Minson, Emma Verner, Pratyush Giri, Jason Butler, Wojt Janowski, Chan Y. Cheah, Sumita Ratnasingam, Shu Min Wong, Matthew Ku, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas K. Yannakou, Fiona Swain, Paul Neeson, Thiago M. Steiner, Javad Saghebi, Piers Blombery, Sally M. Hunter, Molly Robertson, Lei Shong Lau, Rory Bennett, Sean Harrop, Jing Xie, John F. Seymour
More posts featuring Michael Dickinson on OncoDaily.
Adrian Minson
cancer
Chan Y. Cheah
Costas K. Yannakou
Emma Verner
Fiona Swain
Jason Butler
Javad Saghebi
Jing Xie
John F. Seymour
Kirsten Herbert
Lei Shong Lau
Mark Hertzberg
Matthew Ku
Michael Dickinson
Molly Robertson
Nada Hamad
OncoDaily
Oncology
Paul Neeson
Piers Blombery
Pratyush Giri
Rory Bennett
Sally M. Hunter
Sean Harrop
Shu Min Wong
Sumita Ratnasingam
Thiago M. Steiner
Wojt Janowski
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 9, 2025, 09:12
Jul 8, 2025, 20:27
Jul 8, 2025, 18:55